Unfortunately your own politicians dont even agree with you......

First 33 Last

Share
Profile

Follow
pierre77

1,498 Posts.

94

28/07/16

21:39

Post #: 18393125
Share

Originally posted by xrx2gr0 ↑

When the Prana Chief Executive and Board of Directors announce that they have cooperatied with the FDA by submitting requested safety data that was requested last year you can choose to smear the FDA. The PCH would not have been necessary if it had been proven by the end of Phase II for HD that the trial was properly powered and of enough length to establish safety of the dosage that Prana wanted to use for adequate efficacy of PBT2, a clioquinol derivative.

The onus remains on the Prana Chief Executive and Board of Directors to provide requested safety data in a timely manner (too late now) to aid the FDA in determining to lift the PCH and permit Reach2HD to proceed to Phase III. It may be possible that they did submit inadequate information and the FDA's questions remain. If so, we are not being told that.

The idea of placing the blame on the FDA when they are doing their job for public medical safety of a far-from completely-tested HD drug is not sensible... even less sensible is the inference that favoritism of AD "competitors" and timing to coincide with a medical conference has something to do with this whole unfortunate unproductive mess.

Expand

Unfortunately your own politicians dont even agree with you... Just google the top man in FDA Califf ( Maybe Time magazine isn't credible enough for you so I will add some bloggers) ... See below:

http://usuncut.com/politics/bernie-sanders-blocks-obamas-fda-pick-over-ties-to-big-pharma/

http://time.com/3714242/candidate-to-lead-fda-has-close-ties-to-big-pharma/

http://www.alternet.org/news-amp-politics/fda-now-officially-belongs-big-pharma

Such a glowing account of the independence from big pharma and thats just the guy at the top

Last edited by pierre77: 28/07/16

PBT Price at posting: 9.7¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

3 stocks with antimony news on Thursday

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3

ASX Market Open: Local bourse to trade green | Thursday September 12

BRX

Belararox to grow copper footprint in Botswana with 4,286 square km tenure

CHN

Chalice jumps on Putin nickel export ban threat – but then there's bad news

NEC

Nine Entertainment announces its CEO is stepping down – on an ex-divvy day

MTM

Forget gallium: MTM says it's extracted gold from e-waste

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

CU6

Clarity progresses SECuRE trial with positive safety results

SS1

Sun Silver confirms high-grade extension theory at Maverick Springs with 79.6 g/t intercept